Coherus Oncology, Inc. (CHRS)
1.37
+0.02
(+1.48%)
USD |
NASDAQ |
Sep 21, 16:00
1.39
+0.02
(+1.46%)
After-Hours: 20:00
Coherus Oncology Market Cap : 211.62M for Sept. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 21, 2026 | 211.62M |
| September 18, 2026 | 208.54M |
| September 17, 2026 | 190.00M |
| September 16, 2026 | 188.45M |
| September 15, 2026 | 205.45M |
| September 14, 2026 | 220.89M |
| September 11, 2026 | 205.45M |
| September 10, 2026 | 206.99M |
| September 09, 2026 | 203.90M |
| September 08, 2026 | 211.62M |
| September 04, 2026 | 219.35M |
| September 03, 2026 | 211.62M |
| September 02, 2026 | 219.35M |
| September 01, 2026 | 211.62M |
| August 31, 2026 | 208.54M |
| August 28, 2026 | 217.80M |
| August 27, 2026 | 225.53M |
| August 26, 2026 | 223.98M |
| August 25, 2026 | 211.62M |
| August 24, 2026 | 210.08M |
| August 21, 2026 | 219.35M |
| August 20, 2026 | 203.90M |
| August 19, 2026 | 205.45M |
| August 18, 2026 | 206.99M |
| August 17, 2026 | 177.64M |
| Date | Value |
|---|---|
| August 14, 2026 | 185.36M |
| August 13, 2026 | 176.10M |
| August 12, 2026 | 180.73M |
| August 11, 2026 | 186.91M |
| August 10, 2026 | 191.54M |
| August 07, 2026 | 196.18M |
| August 06, 2026 | 195.41M |
| August 05, 2026 | 223.98M |
| August 04, 2026 | 228.62M |
| August 03, 2026 | 222.44M |
| July 31, 2026 | 217.45M |
| July 30, 2026 | 226.70M |
| July 29, 2026 | 217.45M |
| July 28, 2026 | 222.07M |
| July 27, 2026 | 225.16M |
| July 24, 2026 | 217.45M |
| July 23, 2026 | 220.53M |
| July 22, 2026 | 220.53M |
| July 21, 2026 | 226.70M |
| July 20, 2026 | 218.99M |
| July 17, 2026 | 215.90M |
| July 16, 2026 | 214.36M |
| July 15, 2026 | 222.07M |
| July 14, 2026 | 223.62M |
| July 13, 2026 | 226.70M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Enanta Pharmaceuticals, Inc. | 352.64M |
| ACADIA Pharmaceuticals, Inc. | 4.543B |
| Alnylam Pharmaceuticals, Inc. | 32.67B |
| Anika Therapeutics, Inc. | 277.03M |
| Savara, Inc. | 1.119B |
Market Cap Related Metrics
| PS Ratio | 3.549 |
| Price to Book Value | 3.478 |
| Price | 1.37 |
| Earnings Yield | -74.54% |